🔎 Trials Near Me

Hjem › Dermatomyositis › Texas

Dermatomyositis kliniske forsøg i Texas

6 studier for Dermatomyositis søger deltagere på steder i Texas.

Byer i Texas

Officiel studietekst (engelsk)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • og 2 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
  • Houston Methodist Hospital - Accepting Adult Patients, Houston
  • University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  • Integrative Rheumatology of South Texas, Edinburg
  • Arthritis & Rheumatology Research Institute, PLLC, Frisco
  • Integrative Rheumatology of South Texas, Harlingen
  • og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05895786

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • Arthritis & Rheumatology Research Institute, PLLC, Frisco
  • Nerve & Muscle Center of Texas, Houston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06698796

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • Austin Neuromuscular Center, Austin
  • Nerve and Muscle Center of Texas, Houston
RekruttererFase 1
Alder 18 til 85 · Alle køn · Opdateret 22. jul. 2026 · NCT06371417

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.